Pyruvate kinase M2 and cancer: an updated assessment

被引：153
|
作者：
Iqbal, Mohd Askandar [1 ]
Gupta, Vibhor [1 ]
Gopinath, Prakasam [1 ]
Mazurek, Sybille [2 ]
Bamezai, Rameshwar N. K. [1 ]
机构：
[1] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India
[2] Univ Giessen, Inst Vet Physiol & Biochem, D-35392 Giessen, Germany
来源：
FEBS LETTERS | 2014年 / 588卷 / 16期
关键词：
PKM2; Cancer metabolism; Warburg effect; POSITRON-EMISSION-TOMOGRAPHY; HYPOXIA-INDUCIBLE FACTOR-1; ISOENZYME TYPE M2; TUMOR-GROWTH; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; COLORECTAL-CANCER; PROTEIN-KINASE; NUCLEAR TRANSLOCATION; GENE-TRANSCRIPTION;
D O I：
10.1016/j.febslet.2014.04.011
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer cells are characterized by high glycolytic rates to support energy regeneration and anabolic metabolism, along with the expression of pyruvate kinase isoenzyme M2 (PKM2). The latter catalyzes the last step of glycolysis and reprograms the glycolytic flux to feed the special metabolic demands of proliferating cells. Besides, PKM2 has moonlight functions, such as gene transcription, favoring cancer. Accumulating evidence suggests a critical role played by the low-activity-dimeric PKM2 in tumor progression, supported by the identification of mutations which result in the down-regulation of its activity and tumorigenesis in a nude mouse model. This review discusses PKM2 regulation and the benefits it confers to cancer cells. Further, conflicting views on PKM2's role in cancer, its therapeutic relevance and future directions in the field are also discussed. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：2685 / 2692
页数：8
相关论文
共 50 条
  • [41] Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening
    Shastri, Yogesh M.
    Stein, Juergen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (19) : 2768 - 2769
  • [42] The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
    Christofk, Heather R.
    Vander Heiden, Matthew G.
    Harris, Marian H.
    Ramanathan, Arvind
    Gerszten, Robert E.
    Wei, Ru
    Fleming, Mark D.
    Schreiber, Stuart L.
    Cantley, Lewis C.
    NATURE, 2008, 452 (7184) : 230 - U74
  • [43] CURRENT STATUS OF FECAL TUMOR M2 PYRUVATE KINASE IN COLORECTAL CANCER SCREENING
    Ewald, N.
    Tonus, C.
    Koss, K.
    McLoughlin, R. M.
    Hardt, P. D.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3276 - 3276
  • [44] Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer
    Jemal, Mohammed
    Getinet, Mamaru
    Amare, Gashaw Azanaw
    Tegegne, Bantayehu Addis
    Baylie, Temesgen
    Mengistu, Enyew Fenta
    Osman, Enatnesh Essa
    Waritu, Nuredin Chura
    Adugna, Adane
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway
    Zhu, Qiang
    Hong, Baofa
    Zhang, Lei
    Wang, Jing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S616 - S621
  • [46] Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
    Chao, Tai-Kuang
    Huang, Tien-Shuo
    Liao, Yu-Ping
    Huang, Rui-Lan
    Su, Po-Hsuan
    Shen, Hueng-Yuan
    Lai, Hung-Cheng
    Wang, Yu-Chi
    PLOS ONE, 2017, 12 (07):
  • [47] Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2
    Ng, Soo Khai
    Wood, John P. M.
    Chidlow, Glyn
    Peet, Daniel J.
    Casson, Robert J.
    ACTA ONCOLOGICA, 2015, 54 (01) : 136 - 137
  • [48] The Clinicopathological and Prognostic Relevance of Pyruvate Kinase M2 and pAkt Expression in Breast Cancer
    Benesch, Carina
    Schneider, Christine
    Voelker, Hans-Ullrich
    Kapp, Michaela
    Caffier, Hans
    Krockenberger, Mathias
    Dietl, Johannes
    Kammerer, Ulrike
    Schmidt, Melanie
    ANTICANCER RESEARCH, 2010, 30 (05) : 1689 - 1694
  • [49] THE CLINICOPATHOLOGICAL AND PROGNOSTIC RELEVANCE OF PYRUVATE KINASE M2 AND PAKT EXPRESSION IN BREAST CANCER
    Benesch, C.
    Schneider, C.
    Voelker, H. -U.
    Kapp, M.
    Caffier, H.
    Dietl, J.
    Kammerer, U.
    Schmidt, M.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4021 - 4022
  • [50] Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
    El-Far, Ali H.
    Al Jaouni, Soad K.
    Li, Xiaotao
    Fu, Junjiang
    PHYTOTHERAPY RESEARCH, 2022, 36 (08) : 3181 - 3201
12345